Abstract
The definition of COPD adopted in this chapter is that proposed by Burrows [1]:
‘A chronic, slowly progressive airway obstruction disorder resulting from some combination of pulmonary emphysema and irreversible reduction in the calibre of small airways of the lung’.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Burrows, B. (1985). Course and prognosis in advanced disease, in Chronic Obstructive Pulmonary Disease, (ed. T.L. Petty), Marcel Dekker Inc., New York, pp. 31–42.
Fletcher, C. and Peto, R. (1977). The natural history of chronic airflow obstruction. Br. Med. J., i, 1645–8.
Fletcher, C.M., Peto, R., Tinker, C.M. and Speizer, F.E. (1976). The Natural History of Chronic Bronchitis and Emphysema. Oxford University Press, Oxford.
Peto, R., Speizer, F.E., Cochrane, A.L. et al. (1983). The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Am. Rev. Respir. Dis., 128, 491–500.
Lange, P., Nyboe, J., Appleyard, M. et al. (1990). The relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes. Thorax, 45, 579–85.
Speizer, F.E., Fay, M.E., Dockery, D.W. and Ferris, B.G. Jr (1989). Chronic obstructive pulmonary disease mortality in six U.S. Cities. Am. Rev. Respir. Dis., 140, S49–S55.
Burrows, B., Knudson, R.J., Camilli, A.E. et al. (1987). The ‘Horse-Racing effect’ and predicting decline in forced expiratory volume in one second from screening spirometry. Am. Rev. Respir. Dis., 135, 788–93.
Burrows, B. (1991). Predictors of loss of lung function and mortality in obstructive lung diseases. Eur. Respir. Rev., 1, 340–5.
Tweeddale, P.M., Merchant, S., Leslie, M. et al. (1984). Short term variability in FEV1: relation to pretest activity, levels of FEV1, and smoking habits. Thorax, 39, 928–32.
Buist, A.S., Vollmer, W.M., Johnson, L.R. and McCamant, L.E. (1988). Does the single-breath N2 test identify the smoker who will develop chronic airflow limitation? Am. Rev. Respir. Dis., 137, 293–310.
Watson, A., Joyce, H., Hopper, L. and Pride, N.B. (1993). Influence of smoking habits on change in carbon monoxide transfer factor over 10 years in middle-aged men. Thorax, 48, 119–24.
McLean, A., Warren, P.M., Gillooly, M. et al. (1992). Microscopic and macroscopic measurement of emphysema: relation to carbon monoxide gas transfer. Thorax, 47, 144–9.
Gould, G.A., Macnee, W., Mclean, A. et al. (1988). CT measurements of lung density in life can quantitate distal airspace enlargement — an essential defining feature of human emphysema. Am. Rev. Respir. Dis., 137, 380–92.
Knudson, R.J., Kaltenborn, W.T. and Burrows, B. (1989) The effects of cigarette smoking and smoking cessation on the carbon monoxide diffusing capacity of the lung in asymptomatic subjects. Am. Rev. Respir. Dis., 140, 645–51.
Petrik Pereira R., Hunter, D. and Pride, N.B. (1981). Use of lung pressure-volume curves and helium-sulphur hexafluoride washout to detect emphysema in subjects with mild airflow obstruction. Thorax, 36, 29–37.
Corbin, R.P., Loveland, M., Martin, R.R. and Macklem, P.T. (1979) A four-year follow-up study of lung mechanics in smokers. Am. Rev. Respir. Dis., 120, 293–304.
Anthonisen, N.R. (1989) Prognosis in chronic obstructive pulmonary disease: results from multicenter clinical trials. Am. Rev. Respir. Dis., 140, S95–S99.
Weitzenblum, E., Sautegeau, A., Ehrhart, M. et al. (1984). Long-term course of pulmonary arterial pressure in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis., 130, 993–8.
Larsson, C. (1978) Natural history and life expectancy in severe alpha1-antitrypsin deficiency, PiZ. Acta Med. Scand., 204, 345–51.
Tager, I.B., Segal, M.R., Speizer, F.E. and Weiss, S.T. (1988). The natural history of forced expiratory volumes. Effect of cigarette smoking and respiratory symptoms. Am. Rev. Respir. Dis., 138, 837–49.
Doll, R. and Peto, R. (1976) Mortality in relation to smoking: 20 years’ observation on male British doctors. Br. Med. J., 2, 1525–36.
Higenbottam, J., Shipley, M.J., Clark, T.J.H. and Rose, G. (1980) Lung function and symptoms of cigarette smokers related to tar yield and number of cigarettes smoked, Lancet, i, 409–12.
Schenker, M.B., Samet, J.M. and Speizer, F.E. (1982) Effect of cigarette tar content and smoking habits on respiratory symptoms in women. Am. Rev. Respir. Dis., 125, 684–90.
US Department of Health and Human Services (1981). Public Health Service, Office on Smoking and Health. The health consequences of smoking — the changing cigarette: a report of the Surgeon General.
Royal College of Physicians of London (1983) Health or Smoking? Pitman, London.
Krzyanowski, M., Sherrill, D.L., Paoletti, P. and Lebowitz, M.D. (1991) Relationship of respiratory symptoms and pulmonary function to tar, nicotine, and carbon monoxide yield of cigarettes. Am. Rev. Respir. Dis., 143, 306–11.
Lee, P.N. and Garfinkel, L. (1981). Mortality and type of cigarette smoked. J. Epidemiol. Community Health, 35, 16–22.
Withey, C.H., Papacosta, O., Swan, A.V. et al. (1992) Respiratory effects of lowering tar and nicotine levels of cigarettes smoked by young male middle tar smokers. II: Results of a randomised controlled trial. J. Epidemiol. Comm. Health, 46, 281–5.
Becklake, M.R. (1989). Occupational exposures: evidence for a causal association with chronic obstructive pulmonary disease. Am. Rev. Respir. Dis., 140, S85–S89.
Speizer, F.E. (1994) Environmental lung disease, in: Harrison’s Principles of Internal Medicine (eds J.D. Wilson et al.), 13th edn, McGraw-Hill, New York, pp. 1176–83.
Korn, R.J., Dockery, D.W., Speizer, F.E. et al. (1987). Occupational exposures and chronic respiratory symptoms. Am. Rev. Respir. Dis., 136, 296–304.
Xu, X., Christiani, D.C., Dockery, D.W. and Wang, L. (1992) Exposure-response relationships between occupational exposures and chronic respiratory illness: a community-based study. Am. Rev. Respir. Dis., 146, 413–8.
Love, R.G. and Miller, B.G. (1982). Longitudinal study of lung function in coal-miners. Thorax, 37, 193–7.
Marine, W.M., Gurr, D. and Jacobsen, M. (1988) Clinically important respiratory effects of dust exposure and smoking in British coal miners. Am. Rev. Respir. Dis., 137, 106–12.
Oxman, A.D., Muir, D.C., Shannon, H.S. et al. (1993). Occupational dust exposure and chronic obstructive pulmonary disease. A systematic overview of the evidence. Am. Rev. Respir. Dis., 148, 38–48.
Zuskin, E., Ivankovic, D., Schachter, E.N. and Witek, T.J. Jr (1991) A ten-year follow-up study of cotton textile workers. Am. Rev. Respir. Dis., 143, 301–5.
Glindmeyer, H.W., Lefante, J.J., Jones, R.N. et al. (1991) Exposure-related declines in the lung function of cotton textile workers. Am. Rev. Respir. Dis., 144, 675–83.
Enarson, D.A., Vedal, S. and Chan-Yeung, M. (1985) Rapid decline in FEV1 in grain handlers. Am. Rev. Respir. Dis., 132, 814–7.
Davison, A.G., Fayers, P.M., Newman-Taylor, A.J. et al. (1988) Cadmium fume inhalation and emphysema. Lancet, i, 663–7.
Hutchison, D.C.S. (1988) Natural history of alpha-1-protease inhibitor deficiency. Am. J. Med., 84(Suppl. 6A), 3–12.
Bartmann, K., Fooke-Achterrath, M., Koch, G. et al. (1985) Heterozygosity in the Pi-system as a pathogenic cofactor in chronic obstructive pulmonary disease (COPD). Eur. J. Respir. Dis., 66, 284–96.
Lieberman, J., Winter, B. and Sastre, A. (1986) Alpha1-antitrypsin Pi-types in 965 COPD patients. Chest, 89, 370–3.
Hutchison, D.C.S., Tobin, M.J. and Cook, P.J.L. (1983). Alpha1-antitrypsin deficiency: clinical and physiological features in heterozygotes of Pi type SZ. A survey by the British Thoracic Association. Br. J. Dis. Chest, 77, 28–34.
Shigeoka, J.W., Hall, W.J., Hyde, R.W. et al. (1976) The prevalence of alpha1-antitrypsin heterozygotes (PiMZ) in patients with obstructive pulmonary disease. Am. Rev. Respir. Dis., 114, 1077–84.
Morse, J.O., Lebowitz, M.D., Knudson, R.J. and Burrows, B. (1977) Relation of protease inhibitor phenotypes to obstructive lung diseases in a community. N. Engl. J. Med., 296, 1190–4.
Tattersall, S.F., Petrik Pereira, R., Hunter, D. et al. (1979). Lung distensibility and airway function in intermediate alpha1-antitrypsin deficiency (Pi MZ). Thorax, 34, 637–46.
Bruce, R.M., Cohen, B.H., Diamond, E.L. et al. (1984) Collaborative study to assess risk of lung disease in Pi MZ phenotype subjects. Am. Rev. Respir. Dis., 130, 386–90.
Eriksson, S., Lindell, S-E. and Wiberg, R. (1985). Effects of smoking and intermediate alpha1-antitrypsin deficiency (PiMZ) on lung function. Eur. J. Respir. Dis., 67, 279–85.
Silverman, E.K., Pierce, J.A., Province, M.A. et al. (1989). Variability of pulmonary function in alpha1-antitrypsin deficiency: clinical correlates. Ann. Intern. Med., 111, 982–91.
Janus, E.D., Phillips, N.T. and Carrell, R.W. (1985). Smoking, lung function and alpha1-antitrypsin deficiency. Lancet, 1, 152–4.
Buist, A.S., Burrows, B., Eriksson, S. et al. (1983). The natural history of air-flow obstruction in PiZ emphysema. Am. Rev. Respir. Dis., 127, S43–S45.
Troyer, B.E., Silverman, E.K., Wade, M.A. and Campbell, E.J. (1994). α1-antitrypsin deficiency detected through blood donor screening: clinical features and natural history. Am. J. Resp. Crit. Care Med., 149, A1014.
Brumfitt, W., Willoughby, M.L.N. and Bromley, L.L. (1957) An evaluation of sputum examination in chronic bronchitis. Lancet, ii, 1306–9.
Medical Research Council (1965). Definition and classification of chronic bronchitis for clinical and epidemiological purposes. Lancet, i, 775–9.
Medical Research Council (1966) Value of chemoprophylaxis and chemotherapy in chronic bronchitis. Br. Med. J., 1, 1317–22.
Johnston, R.N., McNeill, R.S., Smith, D.H. et al. (1969) Five-year winter prophylaxis for chronic bronchitis. Br. Med. J., 4, 265–9.
Johnston, R.N., McNeill, R.S., Smith, D.H. et al. (1976) Chronic bronchitis — measurements and observations over 10 years. Thorax, 31, 25–9.
Clément, J. and Van de Woestijne, K.P. (1982) Rapidly decreasing forced expiratory volume in one second or vital capacity and development of chronic airflow obstruction. Am. Rev. Respir. Dis., 125, 553–8.
Higgins, M.W., Keller, J.B., Becker, M. et al. (1982) An index of risk for obstructive airways disease. Am. Rev. Respir. Dis., 125, 144–51.
Annesi, I. and Kauffman, F. (1986) Is respiratory mucus hypersecretion really an innocent disorder? Am. Rev. Respir. Dis., 134, 688–93.
Ebi-Kryston, K.L. (1988). Respiratory symptoms and pulmonary function as predictors of 10-year mortality from respiratory disease, cardiovascular disease and all causes in the Whitehall study. J. Clin. Epidemiol., 41, 251–60.
Kryzyzanowski, M. and Wysocki, M. (1986). The relation of thirteen-year mortality to ventilatory impairment and other respiratory symptoms. Int. J. Epidemiol., 15, 56–64.
Kanner, R.S., Renzetti, A.D. Jr, Klauber, M.R. et al. (1979). Variables associated with changes in spirometry in patients with obstructive lung diseases. Am. J. Med., 67, 44–50.
Wang, E.E.L., Prober, C.G., Mansion, B. et al. (1984). Association of respiratory viral infection with pulmonary deterioration in patients with cystic fibrosis. N. Engl. J. Med., 311, 1653–8.
Björkander, J., Bake, B. and Hansion, L.A. (1984). Primary hypogammaglobulinaemia: impaired lung function and body growth with delayed diagnosis and inadequate treatment. Eur. J. Respir. Dis., 65, 529–36.
Björkander, J., Bake, B., Oxelius, V.A. et al. (1985). Impaired lung function in patients with IgA deficiency and low levels of IgG2 or IgG3. N. Engl J. Med., 313, 720–4.
Samet, J.M., Tager, I.B. and Speizer, F.E. (1983) The relationship between respiratory illness in childhood and chronic air-flow obstruction in adulthood. Am. Rev. Respir. Dis., 127, 508–23.
Orie, N.G.M., Sluiter, H.J., De Vries, K. et al. (1961). The host factor in bronchitis, in: Bronchitis, an International Symposium, 27–29 April 1960, University of Grönigen. Royal Van Gorcum, Assen, pp. 43–49.
Pride, N.B., Taylor, R.G., Lim, T.K. et al. (1987). Bronchial hyperresponsiveness as a risk factor for progressive airflow obstruction in smokers. Bull. Eur. Physio-Pathol. Respir., 23, 369–75.
O’Connor, G.T., Sparrow, D. and Weiss, S.T. (1989) The role of allergy and nonspecific airway hyperresponsiveness in the pathogenesis of chronic obstructive pulmonary disease. Am. Rev. Respir. Dis., 140, 225–52.
Burrows, B., Halonen, M., Barbee, R.A. and Lebowitz, M. (1981) The relationship of serum immunoglobulin E to cigarette smoking. Am. Rev. Respir. Dis., 124, 523–5.
Warren, C.P., Holford-Strevens, V., Wong, C. and Manfreda, J. (1982). The relationship between smoking and total immunoglobulin E levels. J. Allergy Clin. Immunol., 69, 370–5.
Taylor, R.G., Gross, E. Joyce, H. et al. (1985). Smoking, allergy and the differential white blood cell count. Thorax, 40, 17–22.
Burney, P.G.J., Britton, J.R., Chinn, S. et al. (1987) Descriptive epidemiology of bronchial reactivity in an adult population: results from a community study. Thorax, 42, 38–44.
Taylor, R.G., Joyce, H., Gross, E. et al. (1985). Bronchial reactivity to inhaled histamine and annual rate of decline in FEV1 in male smokers and ex-smokers. Thorax, 40, 9–16.
Tashkin, D.P., Altose, M.D., Bleecker, E. et al., (1992) The Lung Health Study: airway responsiveness to inhaled methacholine in smokers with mild to moderate airflow limitation. Am. Rev. Respir. Dis., 145, 301–10.
Cockcroft, D.W., Killian, D.N., Mellon, J.A. and Hargreave, F.E. (1977). Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin. Allergy, 7, 235–43.
Woolcock, A.J., Salome, C.M. and Yan, K. (1984). The shape of the dose-response curve to histamine in asthmatic and normal subjects. Am. Rev. Respir. Dis., 130, 171–5.
Sterk, P.J., Daniel, E.E., Zamel, N. and Hargreave, F.E. (1985) Limited bronchoconstriction to methacholine using partial flow-volume curves in nonasthmatic subjects. Am. Rev. Respir. Dis., 132, 272–7.
Du Toit, J.I., Woolcock, A.J., Salome, C.M. et al. (1986). Characteristics of bronchial hyper-responsiveness in smokers with chronic airflow limitation. Am. Rev. Respir. Dis., 134, 498–501.
Higgins, B.G., Britton, J.R., Chinn, S. et al. (1988) Comparison of histamine and methacholine for use in bronchial challenge tests in community studies. Thorax, 43, 605–10.
Ramsdale, E.H., Morris, M.M. and Hargreave, F.E. (1986). Interpretation of the variability of peak flow rates in chronic bronchitis. Thorax, 41, 771–6.
James, A.L., Paré, P.D. and Hogg, J.C. (1989). The mechanics of airway narrowing in asthma. Am. Rev. Respir. Dis., 139, 242–6.
Kuwano, K., Bosken, C.H., Paré, P.D. et al. (1993). Small airways dimensions in asthma and in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis., 148, 1220–5.
Phillips, G.D., Rafferty, P., Beasley, R. and Holgate, S.T. (1987) Effect of oral terfenadine on the bronchoconstrictor response to inhaled histamine and adenosine 5′-monophosphate in non-atopic asthma. Thorax, 42, 939–45.
Tattersfield, A.E. (1987). Effect of beta-agonists and anticholinergic drugs on bronchial reactivity. Am. Rev. Respir. Dis., 136, S64–S68.
Lim, T.K., Turner, N.C., Watson, A. et al. (1990). Effects of nonsteroidal anti-inflammatory drugs on the bronchial hyperresponsiveness of middle-aged male smokers. Eur. Respir. J., 3, 872–9.
Cheung, D., Merkenhof, W.M., Schot, R. et al. (1993) Relationship between indices of parenchymal destruction and maximal airway narrowing in vivo in humans with α1-antitrypsin deficiency. Am. Rev. Respir. Dis., 147, A834.
Bloom, J.W., Halonen, M., Dunn, A.M. et al. (1986). Pneumococcus-specific immunoglobin E in cigarette smokers. Clin. Allergy, 16, 25–32.
Zetterstrom, O., Osterman, K., Machado, L. and Johansson, S.G.O. (1981) Another smoking hazard: raised serum IgE concentration and increased risk of occupational allergy. Br. Med. J., 283, 1215–7.
Venables, K.M., Topping, M.D., Howe, W. et al. (1985). Interaction of smoking and atopy in producing specific IgE antibody against a hapten protein conjugate. Br. Med. J, 290, 201–4.
O’Connor, G.T., Sparrow, D., Segal, M.R. and Weiss, S.T. (1989) Smoking, atopy, and methacholine airway responsiveness among middle-aged and elderly men. Am. Rev. Respir. Dis., 140, 1520–6.
Frette, C., Annesi, I., Korobaeff, M. et al. (1991) Blood eosinophilia and FEV1. Am. Rev. Respir. Dis., 143, 987–92.
Burrows, B., Hasan, F.M., Barbee, R.A. et al. (1980) Epidemiologic observations on eosinophilia and its relation to respiratory disorders. Am. Rev. Respir. Dis., 122, 709–19.
Burrows, B., Knudson, R.J., Clinc, M.G. and Lebowitz, M.D. (1988) A re-examination of risk factors for ventilatory impairment. Am. Rev. Respir. Dis., 138, 829–36.
Higenbottam, T.W., Feyerabend, C. and Clark, T.J.H. (1980). Cigarette smoking in asthma. Br. J. Dis. Chest, 74, 279–84.
Vesterinen, E., Kaprio, J. and Koskenvuo, M. (1988) Prospective study of asthma in relation to smoking habits among 14729 adults. Thorax, 43, 534–9.
Hillerdahl, G. and Rylander, R. (1984) Asthma and cessation of smoking. Clin. Allergy, 14, 45–7.
Burrows, B., Bloom, J.W., Traver, G.A. and Cline, M.G. (1987) The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N. Engl. J. Med., 317, 1309–14.
Tager, I. and Speizer, F.E. (1976) Risk estimates for chronic smokers — a study of male-female differences. Am. Rev. Respir. Dis., 113, 619–25.
Dompeling, E., Van Schayck, C.P, Van Grunsven, P.M. et al. (1993). Slowing the deterioration of asthma and COPD observed during bronchodilator therapy by adding inhaled corticosteroids. Am. Intern. Med., 118, 770–8.
Camilli, A.E., Burrows, B., Knudson, R.J. et al. (1987) Longitudinal changes in forced expiratory volume in one second in adults. Effects of smoking and smoking cessation. Am. Rev. Respir. Dis., 135, 794–9.
Cherniack, R.M. and McCarthy, D.S. (1979). Reversibility of abnormalities of pulmonary function, in The Lung in the Transition Between Health and Disease, (eds P.T. Macklem and S. Permutt), Vol. 12 Dekker, New York, pp. 329–42.
U.S. Department of Health and Human Services (1990) The health benefits of smoking cessation — a report of the Surgeon General. Centers for Disease Control, Office on Smoking and Health, Rockville, Maryland. DHHS Publication No. CDC 90-8416.
Burrows, B., Knudson, R.J., Cline, M.C. and Lebowitz, M.D. (1977). Quantitative relationships between cigarette smoking and ventilatory function. Am. Rev. Respir. Dis., 115, 195–205.
Beck, G.J., Doyle, C.A. and Schachter, E.N. (1981) Smoking and lung function. Am. Rev. Respir. Dis., 123, 149–55.
Dockery, D.W., Speizer, F.E., Ferris, B.G. Jr et al. (1988). Cumulative and reversible effects of lifetime smoking on simple tests of lung function in adults. Am. Rev. Respir. Dis., 137, 286–92.
IPPB Trial Group (1983) Intermittent positive pressure breathing therapy of chronic obstructive pulmonary disease. Ann. Intern. Med., 99, 612–20.
Ashley, F., Kannel, W.B., Soolie, P. and Masson, R. (1975). Pulmonary function: relation to aging, cigarette habit, and mortality. The Framingham Study. Ann. Intern. Med., 82, 739–45.
Cook, D.G., and Shaper, A.G. (1988). Breathlessness, lung function and risk of a heart attack. Eur. Heart J., 9, 1215–22.
Tockman, M.S., Anthonisen, N.R., Wright, E.C. and Donithan, M.G. (1987) IPPB Trial Group, Johns Hopkins Lung Project. Airways obstruction and the risk for lung cancer. Ann. Intern. Med., 106, 512–8.
Burrows, B. (1989) The course and prognosis of different types of chronic airflow limitation in a general population sample from Arizona: comparison with the Chicago ‘COPD’ series. Am. Rev. Respir. Dis., 140, S92–S94.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Pride, N.B., Burrows, B. (1995). Development of Impaired Lung Function: Natural History and Risk Factors. In: Calverley, P.M.A., Pride, N.B. (eds) Chronic Obstructive Pulmonary Disease. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-4525-9_5
Download citation
DOI: https://doi.org/10.1007/978-1-4899-4525-9_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-412-46450-8
Online ISBN: 978-1-4899-4525-9
eBook Packages: Springer Book Archive